Ceapro Inc. CRPOF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

38/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ceapro Inc. (CRPOF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 35/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

38/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

PAST

75/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

21/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — CRPOF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio1.38

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.06

Book Value / Share$0.00

Revenue / Share$0.12

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$0.03	$8.89M	$1.59M	17.9%
2015	$0.08	$10.67M	$4.92M	46.1%
2016	$0.05	$13.67M	$3.62M	26.5%
2017	$-0.01	$12.93M	$-958.28K	-7.4%
2018	$0.00	$11.59M	$-315.54K	-2.7%
2019	$-0.01	$12.88M	$-1.13M	-8.8%
2020	$0.02	$15.12M	$1.86M	12.3%
2021	$0.04	$17.2M	$3.37M	19.6%
2022	$0.06	$18.84M	$4.4M	23.3%
2023	$-0.06	$9.63M	$-4.71M	-48.9%